United States · FDA National Drug Code directory

PNV-DHA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
42192-323_4c39225d-b6a1-5de2-e063-6294a90aa552
Product NDC
42192-323
Form
CAPSULE, GELATIN COATED
Composition / generic term
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent
Labeler
Acella Pharmaceuticals, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20101001 / 20270331

Source-listed ingredients

  • ASCORBIC ACID — 28 mg/1
  • CALCIUM — 160 mg/1
  • FERROUS FUMARATE — 27 mg/1
  • CHOLECALCIFEROL — 400 [iU]/1
  • .ALPHA.-TOCOPHEROL ACETATE, DL- — 30 [iU]/1
  • PYRIDOXINE — 25 mg/1
  • FOLIC ACID — 1.25 mg/1
  • DOCONEXENT — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, GELATIN COATED in 1 BOTTLE (42192-323-30) · 42192-323-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
PNV-DHA — United States | Molindra Medicines